DNAGinkgo Bioworks Holdings

Median target
$7
calls from the last 12 months
Implied return
-10.7%
median target vs. price
Coverage
4 analysts · 4 calls
updated in the last 12 months
Consensus
0/1/3-3 net
Buy / Hold / Sell

Which analysts are behind DNA's consensus?

See every current rating, price target and the analysts' track records for Ginkgo Bioworks Holdings — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 4 analysts with calls on DNA updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

DNA elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-15InsidersHenry Christian ODirectorInsider sale5.0K sh @ $7.08$35K
2026-08-24InsidersCoen Steven P.See remarksInsider sale330 sh @ $6.98$2K

More: insider activity · executive branch · trending